Edition:
United States

Insider Trading: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

350.00USD
22 Jul 2016
Change (% chg)

$9.98 (+2.93%)
Prev Close
$346.80
Open
$345.00
Day's High
$350.00
Day's Low
$345.00
Volume
299
Avg. Vol
1,339
52-wk High
$406.88
52-wk Low
$255.75

SCOTT DAVID

Institutional Holders

% Shares Owned: 96.25%
# of Holders: 321
Total Shares Held: 83,024,977
3 Mo. Net Change: -96,539
# New Positions: 6
# Closed Positions: 4
# Increased Positions: 15
# Reduced Positions: 20
# Net Buyers: -5

Officers & Directors

Name Age Since Current Position

Gregg Powers

52 2014 Independent Chairman of the Board

Namal Nawana

44 2014 President, Chief Executive Officer, Director

James Hinrichs

47 2015 Chief Financial Officer, Executive Vice President

Daniella Cramp

41 2014 Global President - Cardiometabolic Business Unit

Sanjay Malkani

45 2013 Global President - Toxicology

Avi Pelossof

52 2013 Global President - Infectious Disease Business Unit

Ellen Chiniara

56 2014 Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Secretary

John Bridgen

68 2010 Senior Vice President - Business Development

Mark Gladwell

40 2015 Senior Vice President - Global Operations

Melissa Guerdan

41 2014 Senior Vice President - Global Quality and Regulatory Assurance

Robert Hargadon

58 2014 Senior Vice President - Global Human Resources

Renuka Uppaluri

44 2015 Senior Vice President - Global Research and Development

Jonathan Wygant

44 2016 Chief Accounting Officer

Geoffrey Ginsburg

2015 Director

Regina Benjamin

58 2013 Independent Director

Hakan Bjorklund

60 2013 Independent Director

Carol Goldberg

84 2001 Independent Director

John Levy

60 2001 Independent Director

Stephen MacMillan

52 2013 Independent Director

Brian Markison

56 2013 Independent Director

Thomas McKillop

73 2013 Independent Director

John Quelch

63 2003 Independent Director

James Roosevelt

68 2009 Independent Director

Juliet Cunningham

2015 Vice President - Alere Investor Relations